# The Effects of Clostridium Butyricum on Adverse Events During Adjuvant Chemotherapy for Colorectal Cancer

> **NCT07152886** · PHASE4 · NOT_YET_RECRUITING · sponsor: **The Affiliated Hospital of Qingdao University** · enrollment: 238 (estimated)

## Conditions studied

- Colorectal Cancer
- Chemotherapeutic Toxicity

## Interventions

- **DRUG:** Clostridium butyricum capsules
- **OTHER:** placebo capsules

## Key facts

- **NCT ID:** NCT07152886
- **Lead sponsor:** The Affiliated Hospital of Qingdao University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-10-31
- **Primary completion:** 2027-10-31
- **Final completion:** 2027-12-31
- **Target enrollment:** 238 (ESTIMATED)
- **Last updated:** 2025-09-03

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07152886

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07152886, "The Effects of Clostridium Butyricum on Adverse Events During Adjuvant Chemotherapy for Colorectal Cancer". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT07152886. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*